• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测引入筛查后对乳腺癌初级治疗的影响。为卫生保健政策制定提供更全面的情况。

Anticipating the consequences for the primary therapy of breast cancer after introducing screening. A more global picture for health care policy making.

作者信息

Borràs J M, Espinas J A, Beemsterboer P M, Granados A, de Koning H J

机构信息

Catalan Institute of Oncology.

出版信息

Int J Technol Assess Health Care. 1998 Spring;14(2):268-76. doi: 10.1017/s0266462300012241.

DOI:10.1017/s0266462300012241
PMID:9611902
Abstract

A breast cancer screening program mainly aims at reducing mortality. However, it also has an effect, often not assessed, on the utilization of health care resources that is relevant to health care policy making. Using a simulation model, this paper forecasts the impact of introducing a breast cancer screening program on the utilization of resources for the primary therapy of breast cancer. The most important consequences from a health care point of view will be an increased use of breast-conserving therapy and an increased need for postoperative radiotherapy; there will also be a higher number of women diagnosed with noninvasive breast cancer. The results of this study could provide support for health care decision making by showing the consequences of policy decisions on the introduction of screening programs for health care utilization.

摘要

乳腺癌筛查项目主要旨在降低死亡率。然而,它对医疗保健资源的利用也有影响,而这种影响往往未被评估,这与医疗保健政策制定相关。本文使用一个模拟模型预测引入乳腺癌筛查项目对乳腺癌初级治疗资源利用的影响。从医疗保健的角度来看,最重要的后果将是保乳治疗的使用增加以及术后放疗需求的增加;被诊断为非侵袭性乳腺癌的女性数量也会增加。这项研究的结果可以通过展示政策决策对引入筛查项目以用于医疗保健利用的后果,为医疗保健决策提供支持。

相似文献

1
Anticipating the consequences for the primary therapy of breast cancer after introducing screening. A more global picture for health care policy making.预测引入筛查后对乳腺癌初级治疗的影响。为卫生保健政策制定提供更全面的情况。
Int J Technol Assess Health Care. 1998 Spring;14(2):268-76. doi: 10.1017/s0266462300012241.
2
Impact of health technology assessment on preventive screening in Belgium: case studies of mammography in breast cancer, PSA screening in prostate cancer, and ultrasound in normal pregnancy.卫生技术评估对比利时预防性筛查的影响:乳腺癌钼靶筛查、前列腺癌前列腺特异性抗原筛查及正常妊娠超声检查的案例研究
Int J Technol Assess Health Care. 2001 Summer;17(3):316-28. doi: 10.1017/s0266462301106045.
3
Breast cancer screening; cost-effective in practice?乳腺癌筛查;在实际中具有成本效益吗?
Eur J Radiol. 2000 Jan;33(1):32-7. doi: 10.1016/s0720-048x(99)00105-9.
4
5
Health technology assessment and screening in The Netherlands: case studies of mammography in breast cancer, PSA screening in prostate cancer, and ultrasound in normal pregnancy.荷兰的卫生技术评估与筛查:乳腺癌钼靶检查、前列腺癌PSA筛查及正常妊娠超声检查的案例研究
Int J Technol Assess Health Care. 2001 Summer;17(3):369-79. doi: 10.1017/s0266462301106082.
6
Evidence-based screening in the United Kingdom.英国的循证筛查
Int J Technol Assess Health Care. 2001 Summer;17(3):400-8. doi: 10.1017/s0266462301106112.
7
Estimation of the Cost-Effectiveness of Breast Cancer Screening Using Mammography in Mexico Through a Simulation.通过模拟评估墨西哥使用乳房X光检查进行乳腺癌筛查的成本效益
Rev Invest Clin. 2016 Jul-Aug;68(4):184-91.
8
Evaluation of preventive technologies in Germany: case studies of mammography, prostate cancer screening, and fetal ultrasound.德国预防性技术评估:乳腺X线摄影、前列腺癌筛查和胎儿超声的案例研究。
Int J Technol Assess Health Care. 2001 Summer;17(3):329-37. doi: 10.1017/s0266462301106057.
9
Health technology assessment and screening in Sweden.瑞典的卫生技术评估与筛查
Int J Technol Assess Health Care. 2001 Summer;17(3):380-8. doi: 10.1017/s0266462301106094.
10
Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.特定项目成本效益分析:为一个安全网项目制定的乳腺癌筛查政策。
Value Health. 2013 Sep-Oct;16(6):932-41. doi: 10.1016/j.jval.2013.06.013.

引用本文的文献

1
Screen-detected breast cancers have a lower mitotic activity index.筛查发现的乳腺癌有较低的有丝分裂活性指数。
Br J Cancer. 2000 Jan;82(2):381-4. doi: 10.1054/bjoc.1999.0930.